Publications found:
28,647
Sort by:
Psoriatic arthritis - Pipeline Insight, 2021
US$ 2,000.00
... clients within 72 Hours 'Psoriatic Arthritis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Psoriatic Arthritis development. The report provides ...
May 2021
80 pages
Retinitis Pigmentosa - Pipeline Insight, 2021
US$ 2,000.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Retinitis Pigmentosa (Retinitis) The report also ...
May 2021
80 pages
Thyroid cancer - Pipeline Insight, 2021
US$ 2,000.00
... clients within 48 Hours 'Thyroid Cancer - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Thyroid Cancer development. The report provides ...
May 2021
60 pages
Tinnitus - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Tinnitus - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Tinnitus development. The report provides detailed ...
May 2021
60 pages
Traveler’s diarrhea - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Traveler's Diarrhea - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Traveler's Diarrhea development. The report provides ...
May 2021
60 pages
Vascular Dementia - Pipeline Insight, 2021
US$ 1,500.00
... clients within 48 Hours 'Vascular Dementia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Vascular Dementia development. The report provides ...
May 2021
60 pages
Atopic Dermatitis - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Atopic Dermatitis – Pipeline Insight, 2021,” report provides comprehensive insights about 100+ companies and 100+ pipelin...
May 2021
120 pages
Atrial fibrillation - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 24 Hours DelveInsight’s, “Atrial fibrillation - Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15+ pipelin...
May 2021
70 pages
Chagas disease - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Chagas disease – Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs...
May 2021
60 pages
Crohn’s Disease - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Crohn’s Disease - Pipeline Insight, 2021,” report provides comprehensive insights about 80+ companies and 90+ pipeline dr...
May 2021
150 pages
Irritable bowel syndrome - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Irritable bowel syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 24+ companies and 24+ pi...
May 2021
60 pages
Leigh disease - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Leigh disease - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs...
May 2021
60 pages
Major Depressive Disorder - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Major Depressive Disorder – Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies and 50+ p...
May 2021
120 pages
Pneumococcal infections - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Pneumococcal infections – Pipeline Insight, 2021,” report provides comprehensive insights about 15+ companies and 15+ pip...
May 2021
60 pages
Polycystic ovary syndrome - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Polycystic ovary syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ pip...
May 2021
60 pages
Pyoderma gangrenosum - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Pyoderma gangrenosum - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline...
May 2021
60 pages
Sepsis - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Sepsis - Pipeline Insight, 2021,” report provides comprehensive insights about 35+ companies and 35+ pipeline drugs in Se...
May 2021
80 pages
Ulcerative Colitis - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Ulcerative Colitis - Pipeline Insight, 2021,” report provides comprehensive insights about 100+ companies and 110+ pipeli...
May 2021
200 pages
Vasomotor Symptoms - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Vasomotor Symptoms - Pipeline Insight, 2021,” report provides comprehensive insights about 9+ companies and 9+ pipeline d...
May 2021
60 pages
Scleroderma - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Scleroderma - Pipeline Insight, 2021,” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs...
May 2021
100 pages
Global Clinical Trials Market, By Type (Pharmaceutical Trials Vs Medical Device Trials), By Phase (Phase I, Phase II, Phase III, Phase IV), By Study Design (Interventional, Observational, Expanded Access), By Indication (Autoimmune/Inflammation, Oncology, CNS, Diabetes, Cardiovascular, Others), By End User (Clinical Research Organizations, Pharmaceutical and Biotechnological Companies, Clinical Testing Laboratories, Others), By Company, By Region, Forecast & Opportunities, 2026
US$ 4,500.00
Global clinical trials market was valued at USD51.25 billion in 2020 and is anticipated to reach USD77.20 billion by 2026, registering a CAGR of 7.10% in the next five years. The market is driven by t...
May 2021
113 pages
Acute Ischemic Stroke - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Acute Ischemic Stroke – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipel...
May 2021
60 pages
Adenovirus infections - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Adenovirus infections – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipelin...
May 2021
60 pages
Anti-CD20 antibody - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Anti-CD20 antibody – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline...
May 2021
60 pages
Atherosclerosis - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Atherosclerosis – Pipeline Insight, 2021,” report provides comprehensive insights about 25+ companies and 25+ pipeline dr...
May 2021
60 pages
BK Virus infections - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “BK Virus infections – Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline...
May 2021
60 pages
Chronic hand eczema - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Chronic hand eczema - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline...
May 2021
60 pages
Gilles de la Tourette’s syndrome
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Gilles de la Tourette’s syndrome - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and...
May 2021
60 pages
Lipodystrophy - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Lipodystrophy – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipeline drug...
May 2021
60 pages
Methylmalonic academia - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Methylmalonic academia - Pipeline Insight, 2021,” report provides comprehensive insights about 6+ companies and 6+ pipeli...
May 2021
60 pages
Middle East respiratory syndrome - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Middle East respiratory syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies an...
May 2021
60 pages
Neutropenia - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Neutropenia - Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 30+ pipeline drugs...
May 2021
60 pages
Sialorrhoea - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Sialorrhoea – Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in...
May 2021
60 pages
Sleep apnoea syndrome - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Sleep apnoea syndrome – Pipeline Insight, 2021,” report provides comprehensive insights about 10+ companies and 10+ pipel...
May 2021
60 pages
Tendinitis - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Tendinitis - Pipeline Insight, 2021,” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in...
May 2021
60 pages
Vertigo - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Vertigo - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Ver...
May 2021
60 pages
COVID-19 - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “COVID-19 - Pipeline Insight, 2021,” report provides comprehensive insights about 150+ companies and 200+ pipeline drugs i...
May 2021
300 pages
Psoriasis - Pipeline Insight, 2021
US$ 3,000.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Psoriasis - Pipeline Insight, 2021,” report provides comprehensive insights about 100+ companies and 100+ pipeline drugs...
May 2021
200 pages
T cell lymphoma - Pipeline Insight, 2021
US$ 2,500.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “T cell lymphoma - Pipeline Insight, 2021,” report provides comprehensive insights about 100+ companies and 120+ pipeline...
May 2021
200 pages
Brain Metastases - Pipeline Insight, 2021
US$ 2,000.00
This report can be delivered to the clients within 72 Hours DelveInsight’s, “Brain Metastases – Pipeline Insight, 2021,” report provides comprehensive insights about 20+ companies and 20+ pipeline d...
May 2021
60 pages
Thymoma - Pipeline Insight, 2021
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Thymoma – Pipeline Insight, 2021,” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Thy...
May 2021
60 pages
16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021
US$ 3,000.00
16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021 SUMMARY 16S Ribosomal RNA (16S rRNA) - Drugs in Development, 2021 provides in depth analysis on 16S Ribosomal RNA (16S rRNA) targeted pipeline...
April 2021
85 pages
